Drugs / standard immune globulin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00000580 | Nov 1975 → Jun 1986 | hepatitis B virus infection | National Heart, Lung, and Blood Institute (NHLBI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | standard immune globulin | “A total of 205 neonates were assigned to treatment with high-titer hepatitis B immune globulin, standard immune globulin, or albumin placebo within 72 hours of delivery.” NCT00000580 ↗ |
| Modality | Protein / enzyme biologic | “standard immune globulin” NCT00000580 ↗ |
| Route | Intravenous | “immunoglobulins, intravenous” NCT00000580 ↗ |